North America

Blood test developer Inanovate lands $3.1 mln Series C

South Dakota and North Carolina-based Inanovate Inc., a developer of blood tests for cancer and autoimmune diseases, has secured $3.1 million in Series C financing. South Dakota Equity Partners led the round.

New Era raises $60 mln for inaugural fund

New Era Capital Partners, a Tel Aviv-based venture firm, has closed its debut fund at $60 million. The fund will invest in Israeli social impact companies.

Tikehau Capital, Bpifrance invest 38 mln euros in Addev Materials

Tikehau Capital and Bpifrance said April 4 that they are investing 38 million euros ($42.67 million) in Addev Materials. Tikehau made the investment through its pan-European minority growth equity fund. Addev, of Lyon, France, is an industrial company that specializes in the conversion and custom cutting of high-performance materials like insulation, technical films, adhesives, foams.

Tioga Medical raises $15 mln

Tioga Medical said April 4 that it raised $15 million in Series A financing led by The Capital Partnership. Cormorant Healthcare Fund, AMED Ventures, and Shangbay Capital participated in the round. Tioga Media, a Shifamed portfolio company, provides valve replacement solutions for mitral and tricuspid applications that aim to be simpler and less invasive.

Equal Ventures is seeking $40 mln towards its first fund

Clearbanc offers $1 bln in startup funding via 20-Min Term Sheet

Clearbanc, a Toronto-based provider of marketing capital for e-commerce brands, said it will supply $1 billion in growth funding through a new product, the 20-Min Term Sheet. The product will support the rapid provision of $10,000 to $10 million of non-dilutive financing to 2,000 startups in the next 12 months. Clearbanc said the 20-Min Term Sheet offers an alternative to entrepreneurs "pushing back against the traditional VC model for funding" and under-served markets. Founded in 2015 by CEOs Andrew D’Souza and Michele Romanow, Clearbanc secured about $160 million (US$120 million) last year from a syndicate of venture capital firms.

Fintech company Affirm lands $300 mln Series F

Affirm, a fintech company, has raised $300 million in Series F funding. Thrive Capital led the round.

CIBC Innovation Banking puts $5 mln to work in Geoforce

CIBC Innovation Banking, the technology lending arm of CIBC, has provided US$5 million in working capital financing to Geoforce, a Dallas, Texas-based provider of field-asset tracking solutions. Founded in 2007, Geoforce uses hardware and software solutions to help companies in the energy, transportation and services sectors track large assets around the globe. It will use the funds raised to accelerate product delivery and execute on client growth strategies. Geoforce has been backed since 2013 by Houston Ventures, a U.S. energy technology growth equity firm.

Hyde Park Venture Partners to raise venture-capital fund

Hyde Park Venture Partners has set out to raise a third venture-capital fund, according to a filing with the SEC.

Fusion Pharmaceuticals racks up $105 mln Series B

Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company, has raised $105 million in Series B financing. Varian and OrbiMed led the round with participation from other investors that included Perceptive Advisors, Pivotal bioVenture Partners, Rock Springs Capital, Healthcap, Adams Street Partners, Johnson & Johnson Innovation – JJDC Inc, TPG Biotech, Seroba Life Sciences, Genesys Capital and FACIT. In conjunction with the funding, Deepak Khuntia, senior vice president and chief medical officer at Varian, Chau Q. Khuong, a partner at OrbiMed and Heather Preston, a managing director at Pivotal bioVenture Partners, will join Fusion’s board of directors.